Skip to main content
. Author manuscript; available in PMC: 2016 Feb 14.
Published in final edited form as: Nanoscale. 2015 Feb 14;7(6):2805–2811. doi: 10.1039/c4nr07102f

Fig. 1.

Fig. 1

Lung cancer treatment with small molecule chemosensitizers (A) or NP chemosensitizers (B). With small molecule chemosensitizers, there is more normal lung that receives both chemotherapy and chemosensitizer. In contrast, NP chemosensitizers preferrentially accumulate in tumors, which can improve chemosensitizer concentration in tumor while reducing dose to normal lung.